Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

NCT00206557 is registered in ClinicalTrials.gov with The Alfred as lead sponsor.

NCT NCT00206557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00206557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study
Lead sponsor
The Alfred
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2002
Completion date
April 30, 2007
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia, schizophreniform disorder